Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Science Wire.
Press releases published on June 25, 2025
Essential Pharma strengthens Board with the appointment of Nicola Heffron as Non-Executive Director
GlobeNewswire
·
June 25, 2025
Essential Pharma strengthens Board with the appointment of Nicola Heffron as Non-Executive Director Egham, UK – 25 June 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients …
Actimed Therapeutics Enrolls First Patients in Phase 2a PROACT Study Programme to Assess S-pindolol benzoate in Obese Patients During and Post-GLP-1 Agonist Therapy
GlobeNewswire
·
June 25, 2025
Two-part clinical study programme to evaluate change in lean and fat mass in patients receiving two different doses of S-pindolol benzoate whilst 1) receiving the GLP-1 agonist semaglutide; and 2) after cessation of semaglutide treatment Initial proof-of- …
LIfT BioSciences Expands U.S. Footprint with New Facility at Portal Innovations, Houston Helix Park
GlobeNewswire
·
June 25, 2025
LIfT BioSciences Expands U.S. Footprint with New Facility at Portal Innovations, Houston Helix Park London, 25 June 2025– LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, today …
OSE Immunotherapeutics provides an update on ongoing proceedings
GlobeNewswire
·
June 25, 2025
OSE Immunotherapeutics provides an update on ongoing proceedings Nantes, June 25th, 2025, 8:00 a.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces that, following the hearing on June 24th, 2025, regarding the request to retract the …
OSE Immunotherapeutics met à jour l’information sur les procédures en cours
GlobeNewswire
·
June 25, 2025
OSE Immunotherapeutics met à jour l’information sur les procédures en cours NANTES, France, 25 juin 2025, 8 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) annonce qu’à la suite de l’audience le mardi 24 juin 2025, relative à la demande …
Neues Jitterbit-Partnerprogramm schafft globale Plattform für Unternehmensautomatisierung und KI-Agenten
GlobeNewswire
·
June 25, 2025
FRANKFURT, Deutschland, June 25, 2025 (GLOBE NEWSWIRE) -- Jitterbit, ein weltweit führender Anbieter für die Beschleunigung von digitalen Transformationsprozessen in Unternehmenssystemen, hat heute die globale Erweiterung seines Partnerprogramms sowie die …
New Jitterbit Partner Program Enables Global Channel to Deliver Enterprise Automation, AI Agents
GlobeNewswire
·
June 25, 2025
FRANKFURT, Germany, June 25, 2025 (GLOBE NEWSWIRE) -- Jitterbit, a global leader in accelerating business transformation for enterprise systems, today announced the global expansion of its partner program and new Jitterbit University partner curricula. …
NextBillion.ai selects TomTom Orbis Maps to deliver enhanced enterprise-grade solutions globally
GlobeNewswire
·
June 25, 2025
AMSTERDAM, June 25, 2025 (GLOBE NEWSWIRE) -- TomTom (TOM2), the location technology specialist, and NextBillion.ai, a leading provider of AI-powered mapping solutions for enterprise, today announced an expanded partnership to deliver precise route …
Addex Shareholders Approve All Resolutions at Annual General Meeting
GlobeNewswire
·
June 25, 2025
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 25, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today …
Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation
GlobeNewswire
·
June 25, 2025
Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation Ongoing phase 2 study evaluating riliprubart for the potential prevention and treatment of active antibody-mediated rejection in kidney …
Communiqué de presse : Le riliprubart est désigné comme médicament orphelin aux États-Unis pour le rejet induit par les anticorps dans la transplantation d’organes solides
GlobeNewswire
·
June 25, 2025
Le riliprubart est désigné comme médicament orphelin aux États-Unis pour le rejet induit par les anticorps dans la transplantation d’organes solides Étude de phase 2 en cours évaluant le riliprubart pour la prévention et le traitement potentiels du rejet …
WISeSat Signs a Service Agreement with Astrocast to Allow Access to Astrocast’s Operational Satellite Constellation
GlobeNewswire
·
June 25, 2025
FOR IMMEDIATE RELEASE WISeSat Signs a Service Agreement with Astrocast to Allow Access to Astrocast’s Operational Satellite Constellation Geneva, Switzerland – June 25, 2025 – WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a …
ARK 六月势头强劲，Snail Games 庆祝十周年并筹备《夏日海洋》DLC 发布
GlobeNewswire
·
June 25, 2025
《方舟：生存进化》(ARK: Survival Evolved) 六月销量增长超 3,000% Snail 通过电影和音乐合作推广《方舟：夏日海洋》(ARK: Aquatica) 卡尔弗城，加利福尼亚州, June 25, 2025 (GLOBE NEWSWIRE) -- 全球领先的互动数字娱乐领域独立开发商与发行商 Snail, Inc.（纳斯达克股票代码：SNAL，以下简称“Snail Games”或“公司”），以《方舟：生存进化》(ASE) 的强劲六月销售势头为契机，庆祝 ARK 系列发布 10 …
《方舟》6 月氣勢如虹 Snail Games歡慶十周年紀念 迎《Aquatica》上線
GlobeNewswire
·
June 25, 2025
《方舟：生存進化》6 月銷售額飆升超 3000% Snail 攜手影視與音樂合作夥伴，大推《方舟：Aquatica》 加利福尼亞州卡爾弗城, June 25, 2025 (GLOBE NEWSWIRE) -- 全球領先的獨立互動數碼娛樂開發商與發行商 Snail, Inc. (Nasdaq: SNAL)（下稱「Snail Games」或「公司」）歡慶《方舟》系列十周年紀念，《方舟：生存進化》2025 年 6 月銷售氣勢強勁，並針對即將推出的《方舟：Aquatica》 可下載內容展開精準營銷策略。 在近期 …
MiningCoop Crypto Cloud Mining Platform Supports BTC, LTC, DOGE, BCH, and ETC Mining Without Hardware — Launches New Mining Contracts for Crypto Enthusiasts
GlobeNewswire
·
June 25, 2025
London, UK, June 24, 2025 (GLOBE NEWSWIRE) -- Global cloud mining provider MiningCoop has officially launched a new range of multi-currency cloud mining contracts, supporting major cryptocurrencies including Bitcoin (BTC), Litecoin (LTC), Dogecoin (DOGE), …
Array Technologies Announces Pricing of Upsized Offering of Convertible Senior Notes
GlobeNewswire
·
June 25, 2025
ALBUQUERQUE, N.M., June 24, 2025 (GLOBE NEWSWIRE) -- Array Technologies, Inc. (NASDAQ: ARRY) (the “Company” or “ARRAY”) today announced that it has priced an upsized offering of $300 million in aggregate principal amount of 2.875% convertible senior notes …
ZenaTech expande la solución Dron como un Servicio (DaaS) para los sectores gubernamental y de defensa, y firma una oferta para adquirir una empresa de ingeniería y levantamiento topográfico triestatal con sede en Virginia que presta servicios a…
GlobeNewswire
·
June 25, 2025
VANCOUVER, Columbia Británica, June 24, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), una empresa de tecnología especializada en drones con IA (Inteligencia Artificial), Dron como un Servicio (DaaS), software …
Tilray Medical erhält vom italienischen Gesundheitsministerium die erste Genehmigung für den Vertrieb von medizinischen Cannabisblüten für therapeutische Zwecke
GlobeNewswire
·
June 25, 2025
SAVONA, Italien, June 25, 2025 (GLOBE NEWSWIRE) -- Tilray Medical („Tilray“), ein Geschäftsbereich von Tilray Brands, Inc. (NASDAQ: TLRY und TSX: TLRY) und weltweit führender Anbieter von medizinischem Cannabis, der die therapeutische Zusammenarbeit …
Une première autorisation de distribution de la fleur de cannabis médicinal à des fins thérapeutiques délivrée par le ministère de la Santé italien pour Tilray Medical
GlobeNewswire
·
June 25, 2025
SAVONE, Italie, 25 juin 2025 (GLOBE NEWSWIRE) -- Tilray Medical, ci-après « Tilray », une division de Tilray Brands, Inc. (NASDAQ : TLRY et TSX : TLRY) et un leader mondial du cannabis thérapeutique permettant aux patients comme aux professionnels de santé …
Cidara Announces Pricing of Upsized Public Offering of Common Stock
GlobeNewswire
·
June 25, 2025
SAN DIEGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced the pricing of an …